Full-Time
Healthcare Investment Banking Mergers and Acquisitions Associate
Updated on 8/1/2026
Alantra
501-1,000 employees
Global asset management and investment banking
No salary listed
London, UK
In Person
 Finance & Banking (1) |
|---|
Get referred to Alantra
See people who can refer or advise you
- The candidate must have 4–7 years of professional experience.
- The candidate must have an existing affinity with the investment banking sector, gained through academic and corporate finance experience.
- The candidate must have prior involvement in mergers and acquisitions transactions, with full exposure to key execution workstreams.
- The candidate must have strong financial modelling, valuation and analytical skills, with the ability to interpret complex datasets and a high attention to detail.
- The candidate must have a strong understanding of accounting principles and financial statements.
- The candidate must have solid organisational and project management skills and be able to work effectively under pressure and tight deadlines.
- The candidate must be team-oriented, able to collaborate effectively and mentor junior colleagues.
- The candidate must be a self-starter with motivation to build expertise in the healthcare sector.
- Support the execution of Healthcare mergers and acquisitions transactions globally across a range of subsectors.
- Prepare marketing materials and financial analyses.
- Contribute to the day-to-day management of transaction processes.
- Work closely with senior team members and clients to prepare business plans, information memoranda, presentations and supporting financial documentation.
- Contribute to origination efforts and further develop the team’s expertise within the healthcare sector.
Alantra is a global financial group offering asset management, investment banking, and credit portfolio advisory for mid-market clients. Its asset management covers direct investments, funds of funds, co-investments, and secondaries across private equity, active funds, private debt, infrastructure, real estate, and venture capital, managing assets for individuals and institutions. In investment banking, it provides independent M&A, debt advisory, restructuring, and capital markets services with global reach and local market knowledge. Its credit portfolio advisory unit helps structure and optimize loan portfolios across Europe and beyond, aiming to deliver practical financial and investment solutions that grow and protect client value.
Company Size
501-1,000
Company Stage
N/A
Total Funding
$173.8M
Headquarters
Madrid, Spain
Founded
2001
Get referred to Alantra
See people who can refer or advise you
Simplify's Take
What believers are saying
- 2026-2028 plan targets revenue above €330mn and AuM of €10bn.
- Access Capital Partners sale can fund acquisitions and proprietary product expansion.
- London and New York hubs support sector specialization and international origination.
What critics are saying
- Mid-market advisory fees face pressure from larger competitors like Lazard and Houlihan Lokey.
- Plan depends on acquisitions and integrations that can erode margins or distract management.
- Macroeconomic shocks can reduce M&A, fundraising, and capital markets activity across both businesses.
What makes Alantra unique
- Mid-market focus spans investment banking and alternative asset management globally.
- Leading European credit portfolio advisory franchise advised 90-plus transactions worth over €62bn.
- Asset management combines direct investments, fund-of-funds, co-investments, secondaries, and private wealth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Hospitality?
Company News
Alantra has advised Eurotech, a multinational company specialising in edge computers and Internet of Things solutions, on a €17.5 million capital increase through a rights issue. The Italian firm, listed on Euronext STAR Milan, achieved 100% subscription with 20,996,430 new ordinary shares issued. The transaction was executed under authority granted by Eurotech's extraordinary shareholders' meeting in October 2024. Alantra served as financial adviser and global coordinator, supporting the offer structuring and institutional placement process. The successful fundraising reflects strong market confidence in Eurotech's Industrial Plan 2026–2030. The deal strengthens Alantra's equity capital markets track record in Italy, following recent mandates including capital increases for Izertis, Clínica Baviera, Expert.AI and Otofarma.
Alantra has closed a €155 million healthcare continuation fund to scale Health in Code, a clinical genomics platform. The oversubscribed vehicle was led by Hayfin Capital Management, with participation from BNP Paribas AM and Altamar CAM, providing liquidity to existing limited partners at three times invested capital. The transaction introduces Mérieux Equity Partners as a 20% minority shareholder through its buyout fund. Health in Code, formed in 2020 through multiple combinations, operates in over 30 countries, focusing on cardiology, oncology, neurology and rare diseases. Under Alantra's ownership, revenues have more than doubled from €24 million to over €50 million. The company targets €100 million in revenues within five years, with approximately 25% of the new capital earmarked for acquisitions across European markets.
Alantra, a global independent financial services firm, has launched Alteralia Real Estate Debt Fund II with a target size of €200 million, following a first closing. The fund builds on the success of its predecessor, RED I, which has returned nearly two-thirds of capital to investors. RED II will finance high-quality real estate assets across major European markets, supporting top-tier sponsors whilst maintaining a disciplined investment approach with moderate leverage and strong mortgage guarantees. The fund benefits from favourable market conditions, including reduced traditional bank lending and increased refinancing opportunities. The team currently manages a pipeline exceeding €500 million in Europe, with several transactions in advanced stages. Alantra has strengthened the team by appointing Javier Galán as director to expand origination and management capabilities in real estate financing.
Alantra's Klima has secured a €70 million investment to fund fast-growing cleantech companies. The investment will focus on areas supporting decarbonization, such as clean energy generation and storage, energy efficiency, and sustainable transport.
Alantra Partners SA's energy transition fund, Klima, has secured a €70 million commitment from the European Investment Fund. Klima aims to invest in cleantech companies that support decarbonization, clean energy generation and storage, energy efficiency, or sustainable transport.